Marimed (MRMD) Capital Expenditures (2014 - 2026)

Marimed (MRMD) has 13 years of Capital Expenditures data on file, last reported at $373000.0 in Q1 2026.

• Capital Expenditures for Q1 2026 came in at $373000.0, up 40.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 13.55% YoY), and the FY2025 annual result was $1.2 million, down 90.24% from the prior year.
• Capital Expenditures grew to $373000.0 in Q1 2026 per MRMD's latest filing, from $33000.0 in the prior quarter.
• Over five years, Capital Expenditures peaked at $4.0 million in Q1 2022 and troughed at -$10.0 million in Q4 2022.
• A 5-year average of $464882.4 and a median of $1.2 million in 2024 frame the typical range for Capital Expenditures.
• On a YoY basis, Capital Expenditures climbed as much as 1310.26% in 2022 and fell as far as 155.86% in 2022.
• A 5-year view of Capital Expenditures shows it stood at -$10.0 million in 2022, then surged by 55.38% to -$4.5 million in 2023, then soared by 123.75% to $1.1 million in 2024, then slumped by 96.88% to $33000.0 in 2025, then jumped by 1030.3% to $373000.0 in 2026.
• Business Quant data shows MRMD's Capital Expenditures at $373000.0 in Q1 2026, $33000.0 in Q4 2025, and $1.3 million in Q3 2025.